MSB 2.17% $1.13 mesoblast limited

Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L, page-704

  1. 11,171 Posts.
    lightbulb Created with Sketch. 2181
    Yeah, sorry I thought you'd understand the post, but sorry I'll spell it out. We are making headlines. the US market is talking about Mesoblast. that's the point of the post. These were the list of top stocks at the time, plus the link was to the best performing Med stocks on the day. Anyway, that was suppose to be the point of the post...... wasn't clear enough obviously, my bad?

    We made headlines on the Nasdaq website!
    Last edited by kenjikool: 26/04/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.13
Change
-0.025(2.17%)
Mkt cap ! $1.284B
Open High Low Value Volume
$1.15 $1.16 $1.11 $7.363M 6.488M

Buyers (Bids)

No. Vol. Price($)
5 94863 $1.13
 

Sellers (Offers)

Price($) Vol. No.
$1.13 5000 2
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.